| | Identification | Back Directory |  | [Name] 
 EGF816 (S-enantiomer)
 |  | [CAS] 
 1508256-20-9
 |  | [Synonyms] 
 EGF816 (S-enantiomer)
 Nazartinib S-enantiomer (EGF816)
 N-[7-chloro-1-[(3S)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamide
 4-Pyridinecarboxamide, N-[7-chloro-1-[(3S)-1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1H-azepin-3-yl]-1H-benzimidazol-2-yl]-2-methyl-
 |  | [Molecular Formula] 
 C26H31ClN6O2
 |  | [MDL Number] 
 MFCD30534426
 |  | [MOL File] 
 1508256-20-9.mol
 |  | [Molecular Weight] 
 495.02
 | 
 | Chemical Properties | Back Directory |  | [density ] 
 1.28±0.1 g/cm3(Predicted)
 |  | [storage temp. ] 
 Store at -20°C
 |  | [solubility ] 
 DMSO: 50 mg/mL (101.01 mM); Water: < 0.1 mg/mL (insoluble)
 |  | [form ] 
 Solid
 |  | [pka] 
 11.38±0.43(Predicted)
 |  | [color ] 
 White to off-white
 | 
 | Hazard Information | Back Directory |  | [Description] 
 
 Nazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor.
 |  | [Uses] 
 Nazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor.
 |  | [storage] 
 Store at -20°C
 |  | [References] 
 
 [1]. Gerald Lelais, et al. Compounds and compositions for modulating egfr activity. WO 2013184757A1. | 
 | 
                    
                        
                            | Company Name: | Musechem |  
                            | Tel: | +1-800-259-7612 |  
                            | Website: | www.musechem.com |  
                    
                        
                            | Company Name: | InvivoChem |  
                            | Tel: | 13549236410 |  
                            | Website: | https://www.invivochem.cn/ |  |